Ticker Details
Viatris Inc.
IPO Date:	November 13, 2020
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$19.39B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 1.32%
Avg Daily Range (30 D):	$0.25 | 1.64%
Avg Daily Range (90 D):	$0.22 | 1.53%

Institutional Daily Volume
Avg Daily Volume:	8.12M
Avg Daily Volume (30 D):	9.43M
Avg Daily Volume (90 D):	8.11M

Trade Size
Avg Trade Size (Sh.):	186
Avg Trade Size (Sh.) (30 D):	172
Avg Trade Size (Sh.) (90 D):	152

Institutional Trades
Total Institutional Trades:	9,650
Avg Institutional Trade:	$4.64M
Avg Institutional Trade (30 D):	$4.91M
Avg Institutional Trade (90 D):	$5.55M
Avg Institutional Trade Volume:	.39M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$18.04M
Avg Closing Trade (30 D):	$31.2M
Avg Closing Trade (90 D):	$30.8M
Avg Closing Volume:	1.56M

News

May 25, 2026 @ 9:31 AM Tacrolimus Market Research Report 2026: Key Growth... Source: Researchandmarkets.Com

May 11, 2026 @ 5:00 PM Presbyopia Market to Witness Accelerated Growth at... Source: Delveinsight

Apr 10, 2026 @ 10:59 AM Opus Genetics Announces Data Presentations at the ... Source: Na

Apr 2, 2026 @ 7:04 AM Viatris at $14: A Double-Digit FCF Yield Hiding in... Source: Gurufocus

Apr 1, 2026 @ 5:00 PM Systemic Lupus Erythematosus Clinical Trial Pipeli... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.26	$.15	$-.3
Diluted EPS	$-.26	$.15	$-.3
Revenue	$14.56B	$3.52B	$3.7B
Gross Profit	$5.01B	$1.16B	$1.15B
Net Income / Loss	$-296.5M	$176.4M	$-340.1M
Operating Income / Loss	$139.4M	$-79.7M	$-192.7M
Cost of Revenue	$9.55B	$2.36B	$2.56B
Net Cash Flow	$1.05B	$457.7M	$344.5M
PE Ratio

Splits
Oct 09, 2003	3:2
Jan 28, 2003	3:2